Literature DB >> 16429093

Predictors and correlates of high levels of depression and anxiety symptoms among children at age 10.

Sharon L Leech1, Cynthia A Larkby1, Richard Day1, Nancy L Day2.   

Abstract

OBJECTIVE: To identify factors that predict or are correlated with symptoms of depression and anxiety in 10-year-olds.
METHOD: Women and their offspring were followed from the fourth prenatal month through 10 years. There were 636 mother-child pairs at 10 years, a follow-up rate of 83% of the birth cohort. Cognitive, psychological, sociodemographic, and environmental factors were measured at each phase. High depression and anxiety were defined as having a number of symptoms >1 SD above the mean for each measure. These measures were combined to represent high depression and/or anxiety (D/A) at 10 years of age.
RESULTS: Predictors from the prenatal period of D/A at 10 years were more maternal depression symptoms, African American race, less social support, greater household density, and prenatal marijuana exposure. From 18 months through 6 years, lower child IQ, child injuries at age 3, and attention problems predicted symptoms of D/A at age 10. Across all study phases, lower child IQ, household density during pregnancy, attention problems, early childhood injuries, and prenatal marijuana exposure predicted D/A. Maternal psychological and sociodemographic factors were not significant in the final model.
CONCLUSIONS: Factors from gestation and early childhood predict high symptom levels of depression and anxiety at age 10. When gestational exposure, early environmental factors, and child characteristics were considered, maternal depression and socioeconomic status were not significantly associated with early onset D/A. Marijuana exposure during gestation marginally predicted depression/anxiety at age 10.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16429093     DOI: 10.1097/01.chi.0000184930.18552.4d

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  41 in total

Review 1.  Molecular model of cannabis sensitivity in developing neuronal circuits.

Authors:  Erik Keimpema; Ken Mackie; Tibor Harkany
Journal:  Trends Pharmacol Sci       Date:  2011-07-13       Impact factor: 14.819

2.  Heterotyic and homotypic continuity: the moderating effects of age and gender.

Authors:  Wendy M Reinke; Rick Ostrander
Journal:  J Abnorm Child Psychol       Date:  2008-05-07

Review 3.  Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Authors:  Didier Jutras-Aswad; Jennifer A DiNieri; Tibor Harkany; Yasmin L Hurd
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

4.  Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring.

Authors:  Jennifer A DiNieri; Xinyu Wang; Henrietta Szutorisz; Sabrina M Spano; Jasbir Kaur; Patrizia Casaccia; Diana Dow-Edwards; Yasmin L Hurd
Journal:  Biol Psychiatry       Date:  2011-08-05       Impact factor: 13.382

Review 5.  Cannabis use during pregnancy: Pharmacokinetics and effects on child development.

Authors:  Kimberly S Grant; Rebekah Petroff; Nina Isoherranen; Nephi Stella; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2017-08-25       Impact factor: 12.310

6.  Correlation of Minority Status, Cyberbullying, and Mental Health: A Cross-Sectional Study of 1031 Adolescents.

Authors:  Cassandra Duarte; Sarah K Pittman; Margaret M Thorsen; Rebecca M Cunningham; Megan L Ranney
Journal:  J Child Adolesc Trauma       Date:  2018-02-19

7.  Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats.

Authors:  Viviana Trezza; Patrizia Campolongo; Tommaso Cassano; Teresa Macheda; Pasqua Dipasquale; Maria Rosaria Carratù; Silvana Gaetani; Vincenzo Cuomo
Journal:  Psychopharmacology (Berl)       Date:  2008-05-02       Impact factor: 4.530

8.  Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Authors:  Giuseppe Tortoriello; Claudia V Morris; Alan Alpar; Janos Fuzik; Sally L Shirran; Daniela Calvigioni; Erik Keimpema; Catherine H Botting; Kirstin Reinecke; Thomas Herdegen; Michael Courtney; Yasmin L Hurd; Tibor Harkany
Journal:  EMBO J       Date:  2014-01-27       Impact factor: 11.598

9.  National trends in antidepressant medication treatment among publicly insured pregnant women.

Authors:  Krista F Huybrechts; Kristin Palmsten; Helen Mogun; Mary Kowal; Jerry Avorn; Soko Setoguchi-Iwata; Sonia Hernández-Díaz
Journal:  Gen Hosp Psychiatry       Date:  2013-01-30       Impact factor: 3.238

10.  Socioeconomic Status and Internalizing Symptoms in Chilean Children: Does Reserve Capacity Matter?

Authors:  Suzanna M Martinez; Marcela Castillo; Betsy Lozoff; Sheila Gahagan
Journal:  J Child Adolesc Behav       Date:  2015-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.